Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Neoplasms × Magnetic Resonance Spectroscopy × Clear all

Phase

Phase 2 15 Phase 1 10 Phase NA 8 Phase EARLY_PHASE1 3 Phase 1/2 3 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 12 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Urinary Bladder Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Colorectal Neoplasms 4 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Neoplasms 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Glioblastoma 3 Disease 3 Carcinoma 3 Brain Neoplasms 3 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Medulloblastoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Head and Neck Neoplasms 2 Ganglioneuroblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2

Interventions

Gemcitabine 68 Fluorouracil 28 Oxaliplatin 18 Leucovorin 18 Capecitabine 13 130-nm albumin-bound paclitaxel 12 Irinotecan 9 Albumin-Bound Paclitaxel 9 irinotecan sucrosofate 7 Radiotherapy 6 Taxes 5 Erlotinib Hydrochloride 5 folfirinox 4 rubitecan 3 Surgical Procedures, Operative 3 Specimen Handling 3 Pancreaticojejunostomy 3 Neoadjuvant Therapy 3 Drug Therapy 3 Cisplatin 3 ruxolitinib 2 masitinib 2 dehydroftorafur 2 Saline Solution 2 S 1 (combination) 2 Paclitaxel 2 GV1001 peptide 2 Fentanyl 2 Chemotherapy, Adjuvant 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958328 2026-02-02

LAP100

NRG Oncology

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡